128 results
Page 4 of 7
6-K
EX-99.1
kxbnrshf2
17 Sep 13
Fda Approves Teva’s Treanda® (Bendamustine Hci) Injection, a New Liquid Formulation
12:00am
6-K
EX-99.1
ueq87x7
8 Aug 13
Live Filing
12:00am
6-K
leoe2f y767
18 Jul 13
Current report (foreign)
12:00am
6-K
EX-99.1
6rcupc yl
9 Jul 13
Live Filing
12:00am
6-K
EX-99.1
ssru6hxtg
24 Jun 13
Teva launches generic version of Viagra® (sildenafil) in countries across Europe
12:00am
6-K
EX-32.1
5nh4s8xj3141iof
12 Jun 13
Live Filing
12:00am
6-K
EX-99.1
gzz zl5zq2tp0sy8c9i
3 Jun 13
Live Filing
12:00am
6-K
EX-99.1
skxtqgiy t29
8 May 13
Adasuve® (loxapine) inhalation powder is approved in the U.S. for the acute treatment of agitation associated with schizophrenia and bipolar disorder
12:00am
6-K
r488g7w y1
2 May 13
Current report (foreign)
12:00am
6-K
EX-99.1
eg1a3r5s0ug
23 Apr 13
Teva and Xenon Announce FDA Orphan Drug Designation for Pain Drug XEN402
12:00am
6-K
EX-99.1
xx0v9denip74wzr
21 Mar 13
Live Filing
12:00am
6-K
EX-99.1
0h8i9pd64xydyq809ogr
14 Mar 13
Teva to Present New Research on CNS Product Portfolio and Pipeline at 2013 American Academy of Neurology Annual Meeting
12:00am
6-K
EX-99.1
1ld9l9mv krp
22 Feb 13
Additional QNASL® (beclomethasone dipropionate) Nasal Aerosol Data to be Presented at Annual Allergy Meeting
12:00am
6-K
EX-99
9srzw
11 Dec 12
Live Filing
12:00am
6-K
dopyw9
1 Nov 12
Current report (foreign)
12:00am
6-K
EX-99.1
svbqpvg
26 Oct 12
Teva Receives Approval for Synribotm(omacetaxine Mepesuccinate) for Injection
12:00am
6-K
EX-99.1
hchua u6zro
22 Oct 12
PHASE IIa LAQUINIMOD TRIAL RESULTS SHOW POSITIVE DATA FOR POTENTIAL USE IN ACTIVE CROHN’S DISEASE
12:00am
6-K
EX-99.1
kag47lng6q5 n7
10 Oct 12
Teva to Present Positive Data for Glatiramer Acetate 40 MG/1 ML Given Three Times Weekly for Relapsing-remitting Multiple Sclerosis
12:00am
6-K
ra2sv9zn 5fo5
2 Aug 12
Current report (foreign)
12:00am